Your browser doesn't support javascript.
loading
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma.
Merryman, Reid W; Kim, Haesook T; Zinzani, Pier Luigi; Carlo-Stella, Carmelo; Ansell, Stephen M; Perales, Miguel-Angel; Avigdor, Abraham; Halwani, Ahmad S; Houot, Roch; Marchand, Tony; Dhedin, Nathalie; Lescaut, Willy; Thiebaut-Bertrand, Anne; François, Sylvie; Stamatoullas-Bastard, Aspasia; Rohrlich, Pierre-Simon; Labussière Wallet, Hélène; Castagna, Luca; Santoro, Armando; Bachanova, Veronika; Bresler, Scott C; Srivastava, Amitabh; Kim, Harim; Pesek, Emily; Chammas, Marie; Reynolds, Carol; Ho, Vincent T; Antin, Joseph H; Ritz, Jerome; Soiffer, Robert J; Armand, Philippe.
Afiliação
  • Merryman RW; Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Kim HT; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA.
  • Zinzani PL; Institute of Hematology "L. e A. Seràgnoli," University of Bologna, Bologna, Italy.
  • Carlo-Stella C; Humanitas Clinical & Research Center, Milan, Italy.
  • Ansell SM; Department of Oncology and Hematology, University of Milan, Milan, Italy.
  • Perales MA; Mayo Clinic, Rochester, MN.
  • Avigdor A; Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Halwani AS; Division of Hematology and Bone-Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel.
  • Houot R; Huntsman Cancer Institute, Salt Lake City, UT.
  • Marchand T; Centre Hospitalier Universitaire (CHU) Rennes, Service Hématologie Clinique, Rennes, France.
  • Dhedin N; INSERM, Rennes, France.
  • Lescaut W; Centre Hospitalier Universitaire (CHU) Rennes, Service Hématologie Clinique, Rennes, France.
  • Thiebaut-Bertrand A; Hôpital Saint Louis, Service Hématologie Adolescents et Jeunes Adultes, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • François S; Centre Hospitalier Princesse Grace, Service Médecine Interne et Onco-Hématologie, Monaco, France.
  • Stamatoullas-Bastard A; CHU Grenoble, Clinique Universitaire d'Hématologie, Grenoble, France.
  • Rohrlich PS; CHU Angers, Service Maladies du Sang, Angers, France.
  • Labussière Wallet H; Centre Henri Becquerel, Service Hématologie Clinique, Rouen, France.
  • Castagna L; CHU Nice, Service Hématologie et Onco-Hématologie Pédiatrique, Nice, France.
  • Santoro A; Hospices Civils de Lyon, Service d'Hématologie Clinique, Lyon, France.
  • Bachanova V; Humanitas Clinical & Research Center, Milan, Italy.
  • Bresler SC; Department of Oncology and Hematology, University of Milan, Milan, Italy.
  • Srivastava A; Humanitas Clinical & Research Center, Milan, Italy.
  • Kim H; Department of Oncology and Hematology, University of Milan, Milan, Italy.
  • Pesek E; Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN.
  • Chammas M; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and.
  • Reynolds C; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; and.
  • Ho VT; University College of Medicine, Seoul National University, Seoul, South Korea.
  • Antin JH; Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Ritz J; Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Soiffer RJ; Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Armand P; Division of Hematologic Malignancies and Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
Blood ; 129(10): 1380-1388, 2017 03 09.
Article em En | MEDLINE | ID: mdl-28073785

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Linfoma / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Linfoma / Antineoplásicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article